Clinical Trial Update: Does Simvastatin Affect Insulin Sensitivity in Dyslipidemic Type 2 Diabetic Patients? [NA]

View source ↗

Summary

A completed clinical trial investigating whether simvastatin influences insulin sensitivity in dyslipidemic patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hypercholesterolemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Zocor (simvastatin)

Snippet

Sponsor: Medical University of Vienna | Conditions: Hypercholesterolemia, Diabetes | NA | Status: COMPLETED